01.
Immusor
Human Normal Immunoglobulin for I.V Use (5% I.P.)
- Immusor is developed using technology that involves an integrated end to end chromatography process for plasma proteins.
- The traditional method used by other manufacturers is the Cohn’s process of fractionation with ethanol, which is an older technology with less yield and lower purity.
- Immusor is formulated from plasma which is NAT tested and negative for HIV-1, HIV-2, HBV and HCV.
- In addition, two more orthogonal steps are included in the manufacturing process for virus inactivation/removal.
- Immusor is prepared using new, patented technology which has been granted three US patents.
- Immusor is fully complaint with Indian pharmacopeia.